Clinical Trial: Casodex - Nolvadex Combination

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Randomised, Double-blind, Placebo Controlled, Parallel-group, Multicentre Phase II Study to Assess Dose Response Relationship of Nolvadex (Oral Tablet) in Prophylactic Treatment of

  • To describe the extent of gynaecomastia and breast pain by treatment group
  • To describe the relative change from baseline in sex hormones concentrations by treatment group
  • To describe the pharmacokinetics of tamoxifen, N-desmethyltamoxifen and R-bicalutamide when nolvadex is co-administered at varying doses with CASODEX 150 mg once daily
  • To assess the tolerance of nolvadex when co-administered at varying doses with CASODEX 150 mg once daily


  • Original Secondary Outcome: Same as current

    Information By: AstraZeneca

    Dates:
    Date Received: March 12, 2008
    Date Started: November 2002
    Date Completion:
    Last Updated: January 21, 2011
    Last Verified: January 2011